Elite Pharmaceuticals launches generic Tylenol with Codeine tablets across three strengths

ELITE PHARMACEUTICALS INC /NV/

Launched generic acetaminophen/codeine phosphate tablets in 300mg/15mg, 300mg/30mg, 300mg/60mg.
Product marketed under Elite Laboratories label for mild to moderate pain management.
US market for these tablets approximated $47M for 12 months ended May 2024 (IQVIA).
Launch expands Elite's niche generic portfolio; company operates cGMP/DEA facility in Northvale, NJ.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.